Gerards, M C <br/><br/>
Add-on treatment with intermediate-acting insulin versus sliding-scale insulin for patients with type 2 diabetes or insulin resistance during cyclic glucocorticoid-containing antineoplastic chemotherapy: a randomized crossover study.  [electronic resource] 

 -  Diabetes, obesity & metabolism  10 2016 
 - 1041-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12694  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Blood Glucose--drug effects<br/>Cross-Over Studies<br/>Diabetes Mellitus, Type 2--blood<br/>Drug Administration Schedule<br/>Female<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Insulin--administration & dosage<br/>Insulin Resistance--physiology<br/>Male<br/>Middle Aged<br/>Neoplasms--blood<br/>Polypharmacy